Skip to content

Role OF Geometric Mean in Estimation OF Differential Renal Function in DMSA Scintigraphy

Role OF Geometric Mean in Estimation OF Differential Renal Function in DMSA Scintigraphy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05344807
Enrollment
100
Registered
2022-04-25
Start date
2022-05-31
Completion date
2022-11-30
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Referred for Renal DMSA Scintigraphy

Brief summary

Renal scintigraphy is an imaging method that uses small amount of radioactive materials called radiotracers, a Gamma camera and a computer to evaluate kidney functions and its anatomy. The relative renal function (RRF), expressed as a percent of total renal function, is important in the initial assessment and treatment of patients having renal diseases. RRF has traditionally been measured by radionuclide renal scintigraphies using different tracers for a long time . Different radiopharmaceuticals such as technetium-99m-diethylenetriaminepentaacetic acid (99mTc-DTPA), technetium-99m-dimercaptosuccinic acid (99mTc-DMSA), technetium-99m-mercaptoacetyltriglycine (99mTc-MAG3). 99mTc-DMSA is a static agent that is actively taken up by the proximal and distal renal tubular cells, directly from the peritubular vessels and accumulates in the renal cortex. Its binding level to protein in mammals is 90% which prevents significant glomerular filtration. DMSA renal scan images provide a good definition of the cortical outline, as well as they show the relative distribution of functional tissue. Determination of the left to right dimercaptosuccinic acid (DMSA) uptake ratio is theoretically one of the easiest quantitative procedures in nuclear medicine. The quantification can be performed on the posterior view, with or without the lateral view for correction of kidney depth. The geometric mean can also be determined using both the anterior and the posterior views.

Interventions

DIAGNOSTIC_TESTRenal DMSA Scintigraphy

patient injected with Tc99mDMSA then imaged after 2-4 hours by gamma camera

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
2 Years to 70 Years

Inclusion criteria

* Patients referred for renal DMSA scintigraphy * Patients aging 2 to 70 years

Exclusion criteria

* Single kidney patients * Patients with a major uncontrollable medical illness.

Design outcomes

Primary

MeasureTime frameDescription
geometric mean of both anterior and posterior views of gamma camera6 months. We evaluate the discrepancy between function measured by conjugate anterior and posterior views in relationship to posterior view in DMSA scan .

Countries

Egypt

Contacts

Primary Contactshrouk a abdelsalam, resident
shourokatef@med.sohag.edu.eg01141807272
Backup ContactMohamed s gaber, professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026